Metraipolis › archive › dc_72b7a0b87aed

Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities — Europe PMC PMID:41262444

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41262444
DOI
10.3389/fmed.2025.1705723
License (as archived)
solo-consultazione
Archived
2026-11-08T19:35:30.777Z
SHA-256 of the archived text
c1512292738ee3e60d0e0537bd8cb219226f1d2f5cf131a00b23d348bafbabca
Stable URL of this page
https://metraipolis.com/documento/dc_72b7a0b87aed

How to cite

Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities — Europe PMC PMID:41262444 — Europe PMC (en), https://europepmc.org/article/MED/41262444 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72b7a0b87aed (Metraipolis archive dc_72b7a0b87aed, sha256 c1512292738ee3e60d0e0537bd8cb219226f1d2f5cf131a00b23d348bafbabca)
BibTeX
@misc{dc72b7a0b87aed,
  title = {Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities — Europe PMC PMID:41262444},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41262444},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72b7a0b87aed; sha256 c1512292738ee3e60d0e0537bd8cb219226f1d2f5cf131a00b23d348bafbabca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41262444. Agents can read the archived copy with the MCP tool read_document.